AD/PD 2022 - Alzheimer's & Parkinson's Diseases Conference

The AD/PD 2022 – Alzheimer’s & Parkinson’s Diseases Conference will be held as a hybrid conference from 15-20 March 2022, giving you the option to attend either virtually, or physically in Barcelona (Spain).

A central theme of the 2022 conference will be to further advance innovative strategies in therapy and prevention, clinical trials and diagnostic markers, in order to focus on driving successful collaborations among academia and industry, leading to the development of innovative therapies and ultimately providing for a better future for patients and families affected by neurodegenerative diseases.

We are pleased that three AMYPAD abstracts have been accepted for an oral presentation: 

  • Lyduine Collij “Conversion to amyloid positivity:  Predictive value of Global and Regional Centiloid quantification” (Thursday, March 17th, 10:10 AM – 10:25 AM)
  • Luigi Lorenzini “Regional Associations Between White Matter Hyperintensities (WMH) and Amyloid Pathology in Preclinical Alzheimer’s Disease” (Sunday, March 20th, 12:35 PM – 12:50 PM)
  • Mahnaz Shekari “Evaluating the sensitivity of Centiloid quantification to pipeline design” (Saturday, March 19th, 06:15 PM – 06:30 PM)

You can find more about the conference here.